Allogeneic Natural Killer Cells therapy(Kian Immune Cell Company)

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameAllogeneic Natural Killer Cells therapy(Kian Immune Cell Company)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKian Immune Cell Company
China Registration ClassN/A

Develop Information

Active CompaniesKian Immune Cell Company
Inactive CompaniesN/A
Active IndicationsGlioblastomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A